Stocktoria
Axsome Therapeutics, Inc. AXSM
Axsome Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,299,991 | $265.6M | 6.49% |
| TWO SIGMA INVESTMENTS, LP | 679,978 | $166.4M | 1.34% |
| D. E. Shaw & Co., Inc. | 653,353 | $159.9M | 1.28% |
| MILLENNIUM MANAGEMENT LLC | 571,288 | $139.8M | 1.12% |
| CITADEL ADVISORS LLC | 515,178 | $126.1M | 1.01% |
| Point72 Asset Management, L.P. | 479,816 | $117.4M | 0.94% |
| RENAISSANCE TECHNOLOGIES LLC | 262,000 | $64.1M | 0.51% |
| AQR CAPITAL MANAGEMENT LLC | 114,025 | $27.9M | 0.22% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.